Media Coverage

Choose Healthy Life, a national initiative involving Black clergy, United Way of New York City and others, has been awarded a $9.9 million U.S. Department of Health and Human Services grant to expand vaccinations. The federal funding will help establish an infrastructure to start screenings. Quest Diagnostics and its foundation has already provided funding and testing help.

With COVID-19 vaccinations lagging in Georgia, a newly formed coalition launched an initiative Tuesday to convince unvaccinated Georgians to get tested for the virus. With vaccine hesitancy remaining high not only in Georgia but across the country, ACT Against COVID is being rolled out nationwide through a partnership with Quest Diagnostics.

Rusckowski’s company, a top provider of clinical diagnostic services nationwide, received approval from the U.S. Food and Drug Administration on Feb. 29, 2020 to start creating COVID-19 tests. The first tests Quest supplied came March 10, 2020. More than 15 months later, Quest has supplied about 48 million tests.

As screening rates went down for gonorrhea and chlamydia during the COVID-19 pandemic, weekly positivity rates increased, according to Quest Diagnostics’ 2020 Health Trends Study®. The results were published in the American Journal of Preventive Medicine.

GPB's Ellen Eldridge talks with Dr. Harvey Kaufman about a new study showing rates of HCV testing declined during the pandemic. Health experts are now recommending all adults get tested and, if positive for HCV, start treatment early to prevent serious liver disease and death from hepatitis C.